(Q33980853)

30 July 2017

title

Bactericidal activity of quinupristin-dalfopristin against Staphylococcus aureus: clindamycin susceptibility as a surrogate indicator (English)

1 reference

30 July 2017

main subject

Staphylococcus aureus

1 reference

1 reference

2

Barry AL

1 reference

30 July 2017

1

Fuchs PC

1 reference

30 July 2017

3

Brown SD

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 October 2000

1 reference

30 July 2017

number of pages

3

1 reference

Antimicrobial Agents and Chemotherapy

inferred from page(s)

published in

1 reference

30 July 2017

volume

44

1 reference

30 July 2017

issue

10

1 reference

30 July 2017

page(s)

2880-2882

1 reference

Distribution of genes encoding resistance to macrolides, lincosamides, and streptogramins among staphylococci

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90170

Comparative activities of clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, ofloxacin, sparfloxacin, and trovafloxacin and nonquinolones linozelid, quinupristin-dalfopristin, gentamicin, and vancomycin against clinical isolates of ciprofloxa

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90170

The pharmacokinetics of quinupristin/dalfopristin in laboratory animals and in humans

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90170

A review of in-vitro antibacterial activity of quinupristin/dalfopristin against methicillin-susceptible and -resistant Staphylococcus aureus

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90170

Quinupristin/dalfopristin: spectrum of activity, pharmacokinetics, and initial clinical experience

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90170

Critical influence of resistance to streptogramin B-type antibiotics on activity of RP 59500 (quinupristin-dalfopristin) in experimental endocarditis due to Staphylococcus aureus

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90170

In vitro activity of RP 59500, a semisynthetic injectable pristinamycin, against staphylococci, streptococci, and enterococci

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90170

Activity of RP 59500, a new parenteral semisynthetic streptogramin, against staphylococci with various mechanisms of resistance to macrolide-lincosamide-streptogramin antibiotics.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90170

In-vitro activity of streptogramin RP 59500 against staphylococci, including bactericidal kinetic studies

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90170

The in-vitro activity of RP 59500 against gram-positive cocci

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90170

In-vitro activity of RP 59500, a semisynthetic streptogramin, against staphylococci and streptococci

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90170

The in-vitro activity of new streptogramins, RP 59500, RP 57669 and RP 54476, alone and in combination

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90170

RP 59500, a new streptogramin highly active against recent isolates of North American staphylococci

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90170

In-vitro activity of RP 59500, a new semisynthetic streptogramin antibiotic, against gram-positive bacteria

29 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10991879

12 December 2020

inferred from PubMed ID database lookup

Quinupristin-dalfopristin (RP 59500): an injectable streptogramin combination

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10991879

12 December 2020

inferred from PubMed ID database lookup

A phase I, double-blind, placebo-controlled study of the tolerance and pharmacokinetic behaviour of RP 59500

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10991879

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1128/AAC.44.10.2880-2882.2000

1 reference

30 July 2017

1 reference

30 July 2017

1 reference